Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

33 citing papers in PubMed.

1. More than 1Blood · 2017
   Trial
2. Epidemiology and prognostic factors of acute erythroid leukemia.Translational cancer research · 2026
   Article
3. Diagnosis and management of rare acute erythroid leukemia with hemophagocytic lymphohistiocytosis: a case report.Frontiers in oncology · 2026
   Article
4. Successful treatment of multi-hit TP53-mutated myelodysplastic syndromes with erythroid predominance using allogeneic stem cell transplantation and ruxolitinib.Annals of hematology · 2025
   Article
5. [Clinical characteristics and prognosis of acute erythroleukemia in children].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
   Article
6. Acute Erythroid Leukemia: From Molecular Biology to Clinical Outcomes.International journal of molecular sciences · 2024
   Review
7. A Carbon 21 Steroidal Glycoside with Pregnane Skeleton fromPharmaceuticals (Basel, Switzerland) · 2024
   Article
8. Var∣Decrypt: a novel and user-friendly tool to explore and prioritize variants in whole-exome sequencing data.Epigenetics & chromatin · 2023
   Article
9. The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53.Blood · 2023
   Article
10. Erythroleukemia: Classification.EJHaem · 2023
    Article
11. Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia.Blood cancer discovery · 2022
    Article
12. Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.Leukemia · 2021
    Article
13. Molecular Landscapes and Models of Acute Erythroleukemia.HemaSphere · 2021
    Review
14. Erythroleukemia: an Update.Current oncology reports · 2021
    Review
15. Modeling and targeting of erythroleukemia by hematopoietic genome editing.Blood · 2021
    Article
16. Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.Blood · 2020
    Article
17. The non-erythroid myeloblast count rule in myelodysplastic syndromes: fruitful or futile?Haematologica · 2019
    Article
18. Genomic subtyping and therapeutic targeting of acute erythroleukemia.Nature genetics · 2019
    Article
19. Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment concepts.Haematologica · 2018
    Review
20. A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2018
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

14 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as